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Abstract Control of phosphate (Pi) homeostasis is essential for many biological 
functions and inappropriate low levels of Pi in plasma have been suggested to associate 
with several pathological states, including renal stone formation and stone recurrence.  
Pi homeostasis is achieved mainly by adjusting the renal reabsorption of Pi to the body’s 
requirements. This task is performed to a major extent by the Na/Pi cotransporter NaPi-
IIa that is specifically expressed in the brush border membrane of renal proximal tubules. 
While the presence of tight junctions in epithelial cells prevents the diffusion and mixing 
of the apical and basolateral components, the location of a protein within a particular 
membrane subdomain (i.e the presence of NaPi-IIa at the tip of the apical microvilli) 
often requires its association with scaffolding elements which directly or indirectly 
connect the protein with the underlying cellular cytoskeleton. NaPi-IIa interacts with the 
four members of the Na+/H+ exchanger regulatory factor (NHERF) family as well as with 
the GABAA-receptor associated protein (GABARAP). Here we will discuss the most 
relevant findings regarding the role of these proteins on the expression and regulation of 








The need for a proper control of the circulating levels of phosphate (Pi) is illustrated by 
several pathologies associated with either hypo or hyperphosphatemic states. Thus, 
hypophosphatemia compromises bone mineralization and may cause cardiac 
dysfunction, whereas hyperphosphatemia is linked with secondary hyperparathyroidism 
and reduced life expectancy [for review see 3 and 10]. Plasma levels of Pi are kept in the 
low millimolar range due to the balance between intestinal absorption, bone deposition/ 
bone resorption and renal reabsorption [for review see 4]. Since Pi is freely filtered in the 
glomerulus, an efficient renal reabsorption is required to prevent a massive urinary lost 
of Pi that would have otherwise fatal consequences. In this regard, hypophosphatemia 
increases intrarenal production of 1,25 dihydroxyvitamin D3 (1,25(OH)2D3) which in turn 
leads to higher intestinal absorption of Pi and Ca++, with a concomitant increase in 
urinary excretion of Ca++. Hypercalciuria is the most prevalent metabolic alteration in 
renal stone disease and recent studies have suggested that renal reabsorption of Pi is 
reduced in stone formers and associates with hypercalciuria [17]. Moreover, renal 
handling of Pi has been proposed as a predictive factor for renal stone recurrence. 
Among the different hypercalciuric syndromes, hereditary hypophosphatemic rickets with 
hypercalciuria has been recently shown to associate with mutations in one of the 
transporters involved in renal reabsorption of Pi [for review see 3,  10 and 28]. 
 
A. Renal reabsorption of phosphate Reabsorption of Pi from the primary urine takes 
place preferentially along the proximal tubule with very little contribution of the distal 
segments. Several Na-dependent Pi cotransporters from the SLC34 and SLC20 families 
of solute carriers are expressed in the brush border membrane (BBM) of proximal 
tubular cells, namely NaPi-IIa (SLC34A1) [8], NaPi-IIc (SLC34A3) [25] and PiT2 
(SLC20A2) [30]. NaPi-IIa deficient mice are hypophosphatemic due to an increased 
urinary excretion of Pi despite a heavy upregulation of NaPi-IIc [2]. These findings, 
together with the lack of phenotype of NaPi-IIc deficient mice regarding Pi balance [26], 
indicate that NaPi-IIa is the major cotransporter in the murine kidney. Ablation of both 
NaPi-IIa [7] and NaPi-IIc [26] results in hypercalcemia and hypercalciuria; as mentioned 
above, these changes are probably due to a 1,25(OH)2D3-induced upregulation of 
intestinal Ca++ absorption. While disregulation of Ca++ homeostasis results in the 
formation of renal stones in NaPi-IIa deficient mice [7], the absence of NaPi-IIc does not 
seem to increase renal mineral deposition [26]. In humans, mutations of NaPi-IIa have 
been reported in patients with hypophosphatemic syndromes [21]; however, it is no clear 
whether these mutations alone can account for the hypophosphatemic state [31]. 
Instead, mutations in NaPi-IIc have been identified by several laboratories in a large 
number of patients with hereditary hypophosphatemic rickets with hypercalciuria [for 
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review see 3 and 10]. It remains to be shown whether this different relative contribution 
of both cotransporters to overall Pi homeostasis in mouse and human represents a 
species-specific phenomena or responds to yet unknown causes. 
 
Within the murine renal proximal tubule NaPi-IIa is expressed preferentially in the S1 
segments and decreases progressively towards the S2 and S3 portions [8]. Under 
normal dietary conditions it is more abundant in juxtamedular than in superficial 
nephrons. Its expression in the proximal BBM is under the control of several hormones 
(parathyroid hormone (PTH), fibroblast growth factor 23 (FGF23)) and metabolic factors 
(1,25(OH)2D3,  dietary Pi) that regulate renal reabsorption of Pi [for review see 4]. With 
few exceptions, factors that increase renal reabsorption of Pi (Pi deprivation) do so by 
upregulating the apical expression of NaPi-IIa whereas factors that reduce renal 
reabsorption (PTH, FGF23 or high dietary Pi) lead to downregulation of the 
cotransporter. Thus, understanding the molecular mechanisms that control the apical 
expression of NaPi-IIa is a central issue in Pi homeostasis.  
 
B. Interaction of NaPi-IIa with PDZ proteins NaPi-IIa is an integral protein predicted to 
span the membrane 8 to 10 times, with cytoplasmic amino and carboxyl-terminal tails. In 
order to identify potential NaPi-IIa interacting partners, several intracellular segments of 
the cotransporter (amino- and carboxyl-terminal tails as well as the last intracellular loop) 
were first used as bait in yeast two hybrid screenings.  
 
We found that the carboxyl-terminal tail interacts among other partners with the Na+/H+ 
exchanger regulatory factors 1 and 2 (NHERF1/EBP50 and NHERF2/E3KARP) as well 
as with PDZK1/CAP70/NaPi-Cap1 and PDZK2 (Fig. 1A) [11]. These last two proteins 
were recently renamed as NHERF3 and NHERF4, respectively. NHERF1 and NHERF2 
contain 2 PDZ domains (acronym for post synaptic density protein PSD95, Drosophila 
disc large tumor suppressor DlgA, and zonula occludens-1 protein ZO-1) and a carboxyl-
terminal Moesin-Ezrin-Radixin-Merlin (MERM) binding domain that indirectly connects 
with actin. NHERF3 and NHERF4 contain 4 PDZ domains and their binding to the actin 
cytoskeleton has been proposed to be mediated via association with NHERF1. Indeed, 
NHERF1/2 were shown to interact with the fourth PDZ domain of NHERF3 [12]. NaPi-IIa 
interacts specifically with the first PDZ domain of NHERF1/2 and with the third PDZ 
domain of NHERF3/4. In all four cases the association is strictly dependent on the 
presence of the last three residues of NaPi-IIa (TRL) that therefore act as a PDZ-binding 
motif. In our initial screen we found that NHERF3/4 hits represented about 70% of all 
interacting clones, whereas NHERF1/2 hits contributed to less than 10% [11]. This 
observation may just reflect the different relative abundance of transcripts in the kidney 
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cDNA library. However, in vitro analysis indicated that the interaction of NaPi-I (a 
cotransporter which carboxyl-terminal tail has high homology with NaPi-IIa) with 
NHERF3 is stronger that its association with NHERF1 [12]. The four NHERF isoforms 
are coexpressed with NaPi-IIa at the BBM of renal proximal tubules, but their membrane 
expression is not regulated by factors that modulate the apical abundance of the 
cotransporter. 
 
B1. Interaction of NaPi-IIa with NHERF1: functional effect Early experiments showed 
that removal of just the carboxyl-terminal TRL residues of NaPi-IIa results in a protein 
that accumulates massively in the cytoplasm upon transfection in proximal epithelial 
cells, unlike the wild type cotransporter that is expressed preferentially at the apical 
membrane [16]. The finding that the three terminal residues act as a PDZ-binding motif 
allowed us to clarify the molecular mechanism underlying these early observations. 
Thus, we could show that preventing the association of NaPi-IIa with NHERF1, by 
transfecting OK cells only with the interacting PDZ domain of NHERF1 impairs the apical 
expression of the cotransporter (Fig. 1B) [13]. Together, these findings suggested that 
the association with NHERF1 via the terminal TRL stabilizes the expression of NaPi-IIa 
at the BBM. Such mechanism was confirmed when Shenolikar and colleagues published 
the generation of the NHERF1 knock out. They reported that the absence of NHERF1 
results in a reduced expression of NaPi-IIa in the proximal BBM, leading to an increased 
urinary excretion of Pi and hypophosphatemia [27]. 
 
PTH is a phosphaturic hormone that acts by regulating the apical expression of NaPi-IIa. 
PTH binds to a G-protein coupled receptor able to activate the adenylyl cyclase (AC)/ 
PKA as well as the phospholipase C (PLC)/PKC pathways. Both cascades lead to 
endocytosis and lysosomal degradation of NaPi-IIa [for review see 4]. The AC effect 
seems to be solely mediated via the classical PKA pathway, without contribution of the 
exchange protein directly activated by cAMP (EPAC) [15]. Unlike NaPi-IIa, NHERF1 is 
not endocytosed upon PTH treatment [9], suggesting that the complex of both proteins 
must be dissociated prior to internalization of the cotransporter (Fig. 2A).  Indeed the 
amount of NaPi-IIa that co-immunoprecipitates with NHREF is reduced upon incubation 
with PTH (Fig. 2B).  In addition, incubation with PTH, or pharmacological activation of 
PKA or PKC, leads to hyperphosphorylation of NHERF (Fig. 2C), whereas NaPi-IIa does 
not seem to be phosphorylated either basally or after PTH treatment (Fig. 2D) [9]. Based 
on these observations, we proposed that phosphorylation of NHERF1 could inhibit its 
association with NaPi-IIa, thus rendering a cotransporter with reduced stability at the 
BBM. This hypothesis was later on confirmed by EJ Weinman’s group, who reported that 
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PTH-induced dissociation of NaPi-IIa/NHERF1 complexes involves phosphorylation of a 
serine residue (S77) within the first PDZ domain of NHERF1 [34].  
 
In addition to its role as a scaffold for membrane proteins, NHERF1 is also known to 
mediate the assembly of intracellular signalling molecules [for review see 33]. Thus, 
NHERF1 interacts with both the PTH receptor and PLC, and it has been proposed that 
NHERF may control the intracellular pathway activated upon PTH binding [18]. We had 
previously reported that although activation of apical and basolateral PTH receptors 
results in internalization of NaPi-IIa they do not share similar intracellular pathways. In 
particular, apical receptors seem to activate preferentially the PKC dependent pathway 
whereas basolateral receptors signal preferentially via PKA [29]. Therefore, in 
collaboration with EJ Weinman’s group we investigated whether the effect of 3-34 PTH, 
a PTH fragment that activates exclusively PKC, is preserved in the absence of NHERF1. 
Although 3-34 PTH donwregulated NaPi-IIa in wild type mice, it failed to do so in 
NHERF1 knock outs [6]. This failure associated with the inability of PTH to activate PLC 
in the mutant mice. Since the expression of NHERF1 in the renal epithelia is restricted to 
the BBM, our findings are consistent with the proposal that in the presence of NHERF 
the PTH receptors (apical) signal via activation of the PLC/PKC pathway, whereas in the 
absence of NHERF these receptors (basolateral) would signal preferentially through 
activation of PKA [18]. Therefore, NHERF does not only control the basal expression of 
NaPi-IIa but also the intracellular signals that regulate its abundance. 
 
B2. Interaction of NaPi-IIa with NHERF3: functional effect As mentioned above, 
NHERF3/4 represented about 70% of all the hits in our yeast two hybrid screen. In 
addition to NaPi-IIa, NHERF3 also interacts with several other transporters expressed in 
the proximal BBM (Na+/H+ exchanger NHE3, organic cation transporter OCTN1, 
chloride/formate exchanger CFEX and urate/anion exchanger URAT1) as well as with 
regulatory factors (NHERF1 or PKA-anchoring protein D-AKAP2) [12]. Due to the 
presence of 4 PDZ domains, NHERF3 may form a large network of membrane proteins 
and regulatory factors. Similarly to NHERF1, the expression of NHERF3 remains 
unaffected upon incubation of kidney samples with PTH, suggesting that PTH also 
destabilizes its association with NaPi-IIa. Although NHERF3 is phosphorylated under 
basal conditions, PTH or independent activation of PKA or PKC do not regulate the 
phosphorylated status of the protein (Deliot and Hernando, unpublished observations). 
This suggests that NHERF3 is not a target for PTH-activated kinases and that the 
regulated dissociation of NaPi-IIa from NHERF3 does not depend on the same 
molecular mechanism that its dissociation from NHERF1.  
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The membrane expression of NaPi-IIa is not altered in NHERF3 deficient mice that also   
have normal expression of NHERF1 [5]. Regulation of NaPi-IIa by PTH or in response to 
pharmacological activation of PKA and PKC is also normal in these animals. Only upon 
challenging with diets containing high or low Pi levels we could detects subtle differences 
between wild type and NHERF3 deficient mice, namely downregulation of NaPi-IIa in 
response to high dietary Pi is more pronounced in the absence of NHERF3 [5].   
 
Taken together, the four members of the NHERF family interact with NaPi-IIa in vitro but 
they do not have redundant roles in vivo. Instead, NHERF1 is specifically required for the 
stabilization of the cotransporter at the apical membrane and its absence is not 
compensated by the presence of the other isoforms in the BBM.  
 
C. Interaction of NaPi-IIa with GABARAP: functional effect More recently, in 
collaboration with OW Moe’s group we made a new yeast-two hybrid screen using as 
bait the whole NaPi-IIa protein just with the last terminal TRL truncated. This study 
identified the GABAA-receptor associated protein (GABARAP) as a new interacting 
partner of NaPi-IIa [22]. The domain of GABARAP involved in the interaction is located 
between residues 36 and 68, a stretch shown previously to mediate association with 
several other partners, including GABAA receptors [32]. However, the domain of NaPi-IIa 
responsible for the interaction remains elusive, as our attempts to identify it by using 
discrete intracellular domains of NaPi-IIa in GST pull down assays failed.  
 
There are a number of studies showing that GABARAP promotes the membrane 
expression of GABAA-receptors in cell culture; however, the localization of these 
receptors is normal in GABARAP deficient mice [20]. We reported that these animals 
have a reduced urinary excretion of Pi associated with upregulation of NaPi-IIa (Fig. 3) 
[22].  NHERF1 is also heavily upregulated in the mutant mice. The molecular explanation 
for this finding remains unknown but does not seem to involve association of GABARAP 
with NHERF1. Despite the defect in renal handling, GABARAP deficient mice have 
normal levels of Pi in serum. This normophosphatemia is most probably due to a 
compensatory reduction of the intestinal absorption of Pi. This compensation is 
suggested by the finding that NaPi-IIb, the major cotransporter involved in intestinal 
absorption of Pi [14, 24], is downregulated in GABARAP knock outs (Fig. 3) [23]. 
Interestingly, also NaPi-IIb deficient mice are normophosphatemic: they seem to 
compensate the reduced intestinal absorption of Pi (due to the absence of NaPi-IIb) with 
an increased renal reabsorption (through upregulation of NaPi-IIa) [24]. Within the 
intestinal tract, NaPi-IIb is located preferentially in the ileum and its expression in under 
control of 1,25(OH)2D3 [for review see 4].  The expression of the 25 hydroxyvitamin D-
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1α hydroxylase (1α-OHase), the enzyme that produces the active form of 1,25(OH)2D3, 
is reduced in the kidneys from GABARAP deficient mice (Fig. 3), whereas the levels of 
the catabolic 24 hydroxylase are similar in both groups [23]. These data are consistent 
with a reduced renal synthesis of 1,25(OH)2D3 in the mutant mice what would in turn 
lead to a reduced expression of NaPi-IIb. Interestingly, both GABARAP and NaPi-IIb 
deficient mice are normocalcemic; however, while urinary excretion of Ca++ is normal in 
the absence of GABARAP [23], it is increased in NaPi-IIb deficient animals [24].  There 
is no information regarding the presence of renal mineral deposits in these animals. 
 
Although GABARAP was first identified as a ligand of the γ−subunit of GABAA receptors, 
it was later on shown to interact with several proteins involved in intracellular trafficking 
among them the clathrin heavy chain [for review see 19]. We have evidences that PTH-
induced endocytosis of NaPi-IIa takes place at least partially via clathrin-coated pits [1], 
opening the question of whether the absence of GABARAP would blunt the hormonal 
effect. However PTH downregulates the expression of NaPi-IIa to comparable levels in 
wild type and GABARAP deficient mice. Similarly, there are not differences in the 
adaptation of the cotransporter to acute dietary Pi changes [22].  
 
In summary, NaPi-IIa interacts with the NHERF family of PDZ proteins as well as with 
GABARAP. The absence of NHERF1 results in reduced apical expression of NaPi-IIa, 
phosphaturia, hypophosphatemia and impaired PKC-mediated PTH regulation. In 
contrast, the absence of GABARAP results in increased apical expression of NaPi-IIa, 
and reduced urinary excretion of Pi. However, circulating levels of Pi remain normal 
probably due to an intestinal compensation.  
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Figure 1: NaPi-IIa interacts with the four members of the NHERF1 family Schematic 
representation of NaPi-IIa and the four members of the NHERF family located on the 
brush border membrane (BBM) of renal epithelial cells (1A): the interacting PDZ-
domains of the NHERF proteins are indicated by asterisks. The Moesin-Ezrin-Radixin-
Merlin-binding domain (MERM-BD) of NHERF1/2 interacts with the MERM family of 
actin-binding proteins, providing a bridge to the actin cytoskeleton. Preventing the 
association of NaPi-IIa with NHERF1 impairs the apical expression of NaPi-IIa (1B; 
modify from ref 13): confocal microscopy of OK cells transfected with a plasmid encoding 
the myc-fused PDZ1 of NHERF1. Cultures were stained for myc-PDZ1 (red), the 
endogenous NaPi-IIa (green) and actin (white). The patches represent actin-enriched 
apical microdomains were NaPi-IIa is predominantly enriched. The transfected myc-
PDZ1 has a dominant negative effect, as indicated by the observation that cells 
expressing myc-PDZ1 have a reduced expression of NaPi-IIa in the apical microvilli 
despite a normal actin cytoskeleton.      
 
Figure 2: PTH regulates the association of NaPi-IIa and NHERF1 and increases 
the phosphorylation of NHERF1 Schematic representation of the PTH-induced effects 
(2A): binding of PTH to its receptor results in phosphorylation of NHERF1 (1), 
dissociation of NaPi-IIa/NHERF1 complexes (2) and endocytosis of NaPi-IIa (3). PTH 
treatment reduces the amount of NaPi-IIa that coimmunoprecipitates (co-IP) with 
NHERF1 (2B; ref 9): OK cells were transfected with V5-tagged NaPi-IIa. Cultures were 
treated with leupeptin (to prevent lysosomal degradation) followed by incubation in the 
absence (-) or presence (+) of 1-34 PTH. Upon cellular lysis, NHERF1 was 
immunoprecipitated with an NHERF antibody, and the immunoprecipitated material was 
processed for Western blot with V5 and NHERF1 antibodies. *** P ≤ 0.001. PTH 
treatment leads to phosphorylation of NHERF1 (2C; ref 9): slices of mouse kidneys 
were phosphorylated in the presence of 32P followed by incubation in the absence (-) or 
presence (+) of 1-34 PTH. NHERF1 was then pulled down using GST fused to the C-
terminal tail of NaPi-I (GST-CT). Upon elution, samples were analyzed for 32P 
incorporation (top panels) or processed for Western blot with NHERF1 antibodies 
(bottom panel). PTH treatment does not induce phosphorylation of NaPi-IIa (2D; ref 9): 
kidney slices were phosphorylated in the presence of 32P and leupeptin followed by 
incubation in the absence (-) or presence (+) of 1-34 PTH. NaPi-IIa was pulled down 
using GST fused to PDZK1 (GST-K1) and process as indicated above. The top panel 




Figure 3: Expression of Na/Pi-cotransporters in the absence of GABARAP 
GABARAP deficient mice (KO) show an increased expression of NaPi-IIa in renal BBM 
and a reduced expression of NaPi-IIb in BBM from ileum as compared with wild type 
mice (WT). The net effect of both changes probably explains the normophosphatemia in 
the mutant mice. Graphics show the quantification of cotransporters as their ratio to the 
amount of actin (ref 22 and 23). The mRNAs levels of the 25 hydroxyvitamin D-
1αhydroxylase (1α-OHase) are reduced in kidneys from GABARAP deficient mice; 
therefore, a low renal production of 1,25(OH)2D3 could be responsible for the reduced 
expression of NaPi-IIb in these mice. The graphic shows the quantification of 1α-OHase 
mRNA normalized to the hypoxanthine-guanine phosphoribosyltransferase (ref 23).  * P 
≤ 0.05, ** P ≤ 0.01 
 
 
 
